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Background: Although coronary spasm plays an important role in the pathogenesis of ischemic heart disease, its impact on non-ST-segment 
elevation acute coronary syndrome (NSTE-ACS) has not been fully elucidated. We evaluated the prevalence, clinical features, and long-term outcome 
of NSTE-ACS caused by coronary spasm in Japanese patients. 
methods: We studied consecutive 1,601 patients with suspected NSTE-ACS who underwent cardiac catheterization between January 2001 and 
December 2010. 
results: Significant organic coronary stenosis was found in 1,152 patients (72%, obstructive group). In patients without significant organic 
stenosis, coronary spasm was verified in 145 patients with spontaneous attacks, and verified in 175 out of 221 patients who underwent 
acetylcholine provocation test. Spasm-induced NSTE-ACS was diagnosed in 320 patients (20%, spasm group). Multivariate analysis showed that 
patients of the spasm group had the following features: age <70 years (odds ratio [OR] 1.81, 95% confidence interval [CI]: 1.25-2.62, p<0.01), 
female (OR 1.51, 95% CI: 1.05-2.17, p=0.03), no hypertension (OR 2.26, 95% CI: 1.65-3.11, p<0.01), no dyslipidemia (OR 2.51, 95% CI: 1.82-3.47, 
p<0.01), no diabetes mellitus (OR 2.07, 95% CI: 1.46-2.96, p<0.01), no history of myocardial infarction (OR 2.60, 95% CI: 1.33-5.13, p<0.01), 
eGFR ≥60ml/min/1.73m2 (OR 1.73, 95% CI: 1.14-2.62, p=0.01), TIMI risk score ≤2 (OR 2.53, 95% CI: 1.70-3.77, p<0.01), and no elevated cardiac 
biomarkers (OR 2.35, 95% CI: 1.70-3.26, p<0.01). During 19±8 months of follow-up, cardiovascular death, myocardial infarction, unstable angina, 
stroke, and heart failure were less frequently observed in patients of the spasm group than the obstructive group (5% vs 13%, p<0.01). Multivariate 
Cox hazard analysis identified the spasm group as one of the independent predictors of long-term outcome (hazard ratio 0.55, 95% CI: 0.32-0.96, 
p=0.03). 
conclusions: The present study found the frequent involvement of coronary spasm in the pathogenesis of NSTE-ACS in Japanese patients. Coronary 
spasm should be considered even in patients with less coronary risk factors and non-obstructive coronary arteries.
